Research Topics
| Marco VitoriaSummaryAffiliation: World Health Organization Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challengesMarco Vitoria
Department of HIV AIDS, World Health Organization, Geneva, Switzerland
Curr Opin HIV AIDS 8:12-8. 2013....- The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectivesMarco Vitoria
World Health Organization, HIV Dept, Geneva, Switzerland
Am J Clin Pathol 131:844-8. 2009..Investment in strategic information and public health laboratory network capacity strengthening are key actions to expand services to successfully address those diseases in heavily impacted countries... 
Highly active antiretroviral treatment for the prevention of HIV transmissionReuben Granich
Department of HIV AIDS, World Health Organization, Geneva, Switzerland
J Int AIDS Soc 13:1. 2010..To explore HAART as a prevention strategy, we recommend further discussions to explore human rights and ethical considerations, clarify research priorities and review feasibility and acceptability issues...- Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and updateReuben Granich
Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Geneva, Switzerland
Curr Opin HIV AIDS 5:298-304. 2010..This review examines HAART as a potential tool for preventing HIV transmission... 
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settingsCharles F Gilks
Department of HIV AIDS, World Health Organization, Geneva 1211, Switzerland
Lancet 368:505-10. 2006..Simplified operational guidelines, tools, and training materials enable clinical teams in primary-care and second-level facilities to deliver HIV prevention, HIV care, and ART, and to use a standardised patient-tracking system...- Determinants of HIV drug resistance and public health implications in low- and middle-income countriesSilvia Bertagnolio
HIV Department, World Health Organization, Geneva, Switzerland
Antivir Ther 17:941-53. 2012..Additionally, we summarize the World Health Orgnization's global HIVDR surveillance and prevention strategy and describe resulting public health and policy implications... - Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050Reuben Granich
HIV AIDS Department, World Health Organization, Geneva, Switzerland
PLoS ONE 7:e30216. 2012..Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa... - Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisReuben Granich
Antiretroviral Treatment and HIV Care Unit, Department of HIV AIDS, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
Curr HIV Res 9:355-66. 2011..This review analyzes the gaps and summarizes the evidence regarding ART in the prevention of HIV and TB... - Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimensFrançoise Renaud-Théry
Department of HIV AIDS, World Health Organization, CH 1211 Geneva 27, Switzerland
AIDS 21:S89-95. 2007..To address the information gap on current use of antiretroviral drugs (ARTs) in developing countries... - Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African settingLouisa Jones
World Health Organization, Geneva, Switzerland
Curr HIV Res 9:416-28. 2011..ART programs should consider measuring the cost and impact of human rights and community support interventions as key aspects of successful programme expansion... - Antiretroviral therapy in prevention of HIV and TB: update on current research effortsReuben Granich
Antiretroviral Treatment and HIV Care, Department of HIV AIDS, Building D, 1st Floor, Room 1005, World Health Organization, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
Curr HIV Res 9:446-69. 2011..The large number and wide variety of research projects emphasise the importance of this research issue and clearly demonstrate the potential for synergies, partnerships and coordination across funding agencies... - National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?Eduard J Beck
HIV Department, World Health Organization, Geneva, Switzerland
AIDS 20:1497-502. 2006..To investigate the existence of national adult antiretroviral therapy (ART) guidelines in 43 World Health Organization (WHO) '3 by 5' focus countries and compare their content with the 2003 WHO ART guidelines... - Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countriesFrançoise Renaud-Théry
Department of HIV AIDS, World Health Organization, 1211 Geneva, Switzerland
AIDS Res Treat 2011:749041. 2011.... - Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer
Medecins Sans Frontieres, Geneva, Switzerland
J Int AIDS Soc 15:17986. 2012..This commentary reviews recommendations made in an expert consultation on treatment scale up in resource-limited settings... - Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensusSteven T Wiersma
World Health Organization, FCH IVB, Geneva, Switzerland
Liver Int 31:755-61. 2011..In addition, a research agendum was developed focusing on issues related to prevention and treatment of chronic HBV in resource-constrained settings...